CLSD Stock Summary and Trading Ideas (Clearside Biomedical | NASDAQ:CLSD)

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Clearside Biomedical trades on the NASDAQ stock market under the symbol CLSD.

As of April 19, 2024, CLSD stock price declined to $1.31 with 225,827 million shares trading.

CLSD has a beta of 2.69, meaning it tends to be more sensitive to market movements. CLSD has a correlation of 0.21 to the broad based SPY ETF.

CLSD has a market cap of $97.88 million. This is considered a Micro Cap stock.

Last quarter Clearside Biomedical reported $6 million in Revenue and -$.08 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.01.

In the last 3 years, CLSD stock traded as high as $7.73 and as low as $.65.

The top ETF exchange traded funds that CLSD belongs to (by Net Assets): VTI, VXF, IWC.

CLSD has underperformed the market in the last year with a return of +17.0%, while the SPY ETF gained +21.2%. In the last 3 month period, CLSD fell short of the market, returning +1.6%, while SPY returned +4.3%. However, in the most recent 2 weeks CLSD has outperformed the stock market by returning -1.5%, while SPY returned -3.5%.

CLSD support price is $1.24 and resistance is $1.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLSD stock will trade within this expected range on the day.